Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle

Share this story

WAYNE, Pa.–(BUSINESS WIRE)– #CLI–Cagent Vascular, a leader in innovative endovascular technologies, today announced the publication of a peer-reviewed study in the Journal of Endovascular Therapy (JEVT) demonstrating the safety and efficacy of the Serranator® PTA Serration Balloon Catheter in pedal (inframalleolar) interventions for patients with chronic limb-threatening ischemia (CLTI). The investigator-initiated, multi-institutional, retrospective study, led by Dr. Edward Gifford, vascular surgeo

See full post here as originally published on this site